Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML.
Scandura JM, Roboz GJ, Moh M, Morawa E, Brenet F, Bose JR, Villegas L, Gergis US, Mayer SA, Ippoliti CM, Curcio TJ, Ritchie EK, Feldman EJ.
Scandura JM, et al.
Blood. 2011 Aug 11;118(6):1472-80. doi: 10.1182/blood-2010-11-320093. Epub 2011 May 25.
Blood. 2011.
PMID: 21613261
Free PMC article.
Clinical Trial.